Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycoses associated with AIDS in the Third World.

S A Marques1, A M Robles, A M Tortorano

  • 1Departamento de Dermatologia, Faculdade de Medicina de Botucatu-UNESP, Brazil. smarques@fmb.unesp.br

Medical Mycology
|February 24, 2001
PubMed
Summary

Human immunodeficiency virus (HIV) infection remains a significant global health challenge, particularly in developing nations. Fungal infections are a major concern for individuals with acquired immunodeficiency syndrome (AIDS), with varying prevalence based on geographic location and fungal species.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enrofloxacin induces mild and transient vascular alterations following regional limb perfusion in horses.

Journal of equine veterinary science·2026
Same author

Fenestration of the maxillary septal bulla using different surgical approaches and endoscopy systems in horses: An ex vivo study.

Journal of equine veterinary science·2024
Same author

Trends in the molecular epidemiology and population genetics of emerging <i>Sporothrix</i> species.

Studies in mycology·2022
Same author

Mycosands: Fungal diversity and abundance in beach sand and recreational waters - Relevance to human health.

The Science of the total environment·2021
Same author

Evolution of fungemia in an Italian region.

Journal de mycologie medicale·2019
Same author

Clinical and microbiological characteristics of paracoccidioidomycosis in patients with AIDS in Buenos Aires, Argentina.

Medical mycology·2019

Area of Science:

  • Mycology
  • Infectious Diseases
  • Epidemiology

Background:

  • Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) continue to pose significant public health challenges globally, especially in developing regions.
  • Fungal infections are a critical co-morbidity in individuals with AIDS, with specific pathogens prevalent in different endemic areas.
  • While some fungal infections are common worldwide, others are geographically restricted, and certain rare fungal groups are emerging as causes of disease in AIDS patients.

Purpose of the Study:

  • To review the epidemiological status of HIV infection and its associated fungal diseases worldwide.
  • To highlight the prevalence and significance of various fungal pathogens in the context of AIDS.
  • To discuss the epidemiological, clinical, and therapeutic aspects of superficial mycoses in HIV-infected individuals.

Related Experiment Videos

Main Methods:

  • Review of epidemiological data on HIV infection rates in various global regions.
  • Analysis of the incidence and prevalence of fungal infections in patients with AIDS.
  • Discussion of specific fungal agents, including Candida, Cryptococcus, Histoplasma, Coccidioides, Penicillium, Sporothrix, Blastomyces, Paracoccidioides, Aspergillus, and dermatophytes.

Main Results:

  • HIV infection rates are increasing in Sub-Saharan Africa, Southeast Asia, and India, with 1.6 million cases in Latin America and the Caribbean by 1997.
  • Candida species and Cryptococcus neoformans are common worldwide fungal infections in AIDS patients.
  • Histoplasma capsulatum, Coccidioides immitis, and Penicillium marneffei are significant in endemic areas, while Aspergillus spp. incidence is increasing.

Conclusions:

  • Fungal diseases are a major diagnostic consideration in AIDS patients, with geographic location influencing pathogen prevalence.
  • While some fungal infections are well-established, others like Aspergillus are emerging.
  • Superficial mycoses present unique epidemiological, clinical, and therapeutic challenges in the context of HIV/AIDS.